Brian M. Hahn
2017
In 2017, Brian M. Hahn earned a total compensation of $798.4K as Chief Financial Officer at GlycoMimetics, a 19% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $167,616 |
|---|---|
| Option Awards | $277,550 |
| Salary | $349,200 |
| Other | $4,050 |
| Total | $798,416 |
Hahn received $349.2K in salary, accounting for 44% of the total pay in 2017.
Hahn also received $167.6K in non-equity incentive plan, $277.6K in option awards and $4.1K in other compensation.
Rankings
In 2017, Brian M. Hahn's compensation ranked 10,041st out of 14,666 executives tracked by ExecPay. In other words, Hahn earned more than 31.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,041 out of 14,666 | 32nd |
Division Manufacturing | 3,880 out of 5,772 | 33rd |
Major group Chemicals And Allied Products | 1,358 out of 2,075 | 35th |
Industry group Drugs | 1,102 out of 1,731 | 36th |
Industry Pharmaceutical Preparations | 863 out of 1,333 | 35th |
Source: SEC filing on April 13, 2018.
Hahn's colleagues
We found three more compensation records of executives who worked with Brian M. Hahn at GlycoMimetics in 2017.
News
GlycoMimetics CEO Harout Semerjian's 2023 pay jumps 67% to $2.4M
April 1, 2024
GlycoMimetics CEO Harout Semerjian's 2022 pay falls 50% to $1.4M
April 21, 2023
GlycoMimetics CEO Harout Semerjian receives $2.9M in 2021
April 11, 2022
GlycoMimetics CEO Rachel King's 2018 pay jumps 105% to $3.2M
April 10, 2019